GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (AHS Cancer Control Alberta)
- Generic Name
- GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (AHS Cancer Control Alberta)
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient with Alveolar Soft Part Sarcoma
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 1
- Registration Number
- NCT06827886
- Locations
- 🇨🇦
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Canada
CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma
Early Phase 1
Active, not recruiting
- Conditions
- SarcomaAlveolar Soft Part Sarcoma (ASPS)
- Interventions
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 1
- Registration Number
- NCT06813417
- Locations
- 🇨🇦
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient with Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 1
- Registration Number
- NCT06789081
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath